Reducing Palivizumab Dose Requirements Through Rational Dose Regimen Design

Reuter, SE; Evans, AM; Ward, MB

Reuter, SE (reprint author), Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019; 8 (1):

Abstract

Palivizumab for respiratory syncytial virus (RSV) immunoprophylaxis in premature infants poses a significant economic challenge. Although standard dos......

Full Text Link